SCHEMBL5122

SCHEMBL5122

CCOC(=O)c1ccc(B(O)O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.63
CA2 P00918 3/20 0.63
CA12 O43570 2/20 0.63
CA7 P43166 2/20 0.63
CA9 Q16790 2/20 0.63
CA14 Q9ULX7 2/20 0.63
ESR1 P03372 1/20 0.63
ESR2 Q92731 1/20 0.63
LMNA P02545 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
MAOA P21397 1/20 0.61
HPGD P15428 4/20 0.54
HTT P42858 2/20 0.54
RECQL P46063 1/20 0.51
ALDH1A1 P00352 1/20 0.51
HSP90AA1 P07900 1/20 0.51
CACNA1B Q00975 1/20 0.51
APBA1 Q02410 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL87450 0.85 CA1 (0.83) CA1CA2CA12CA7CA9
SCHEMBL18541492 0.85 ALDH1A1 (0.66) ESR1LMNACYP1A2CYP3A4HPGD
SCHEMBL23590100 0.84 CA1 (0.58) CA1CA2CA12CA7CA9
SCHEMBL1993193 0.84 CA1 (0.58) CA1CA2CA12CA7CA9
SCHEMBL21440358 0.83 CA1 (0.79) CA1CA2CA12CA7CA9
SCHEMBL29504635 0.83 CA1 (0.79) CA1CA2CA12CA7CA9
SCHEMBL30271267 0.83 CA1 (0.79) CA1CA2CA12CA7CA9
SCHEMBL7746905 0.83 CA1 (0.79) CA1CA2CA12CA7CA9
SCHEMBL27667923 0.83 CA1 (0.79) CA1CA2CA12CA7CA9
SCHEMBL27667917 0.83 CA1 (0.79) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 825 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188096-A1 BENT OXAZOLE-BASED ORGANIC LINKERS FOR THE RETICULAR FORMATION OF METAL-ORGANIC FRAMEWORKS AND METHODS OF PREPARATION THEREOF KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-06-12 US claimed
CN-119613745-A Preparation method and application of series of zirconium-based MOFs and electrochromic film thereof 南开大学 2025-03-14 CN claimed
CN-115959993-B Synthesis method of 2-aryl propionic acid compound 山东中医药大学 2025-01-07 CN claimed
CN-119161578-A Polyimide film with aggregation-induced emission effect and preparation method thereof 西北工业大学 2024-12-20 CN claimed
CN-117417248-B Molecular-level monolayer hydrophilic graphene quantum dot and preparation method thereof 武汉科技大学 2024-11-19 CN claimed
CN-118091444-A Method for rapidly detecting thermal history of lithium ion battery and application 北京化工大学 2024-05-28 CN claimed
CN-118063431-A Preparation method of IPTACOPAN 斯坦德药典标准物质研发(湖北)有限公司 2024-05-24 CN claimed
CN-117924172-A Naphthalimide formaldehyde fluorescent probe and preparation method and application thereof 天津理工大学 2024-04-26 CN claimed
CN-115739189-B Preparation method of nanoparticle composite material for rapidly catalyzing suzuki reaction at room temperature 五邑大学 2024-02-13 CN claimed
CN-117417248-A Molecular-level monolayer hydrophilic graphene quantum dot and preparation method thereof 武汉科技大学 2024-01-19 CN claimed
CN-115283019-A Preparation method and application of porous metal organic framework loaded Ni composite catalyst 吉林领创生物科技有限公司 2022-11-04 CN claimed
CN-114805413-A Substituted phenyl tetraphenyl vinyl boron fluorine complex and preparation method and application thereof 河北科技大学 2022-07-29 CN claimed
WO-2022159439-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2022-07-28 WO claimed
WO-2022026372-A2 PROCESSES FOR PREPARING MODULATORS OF ALPHA-1 ANTITRYPSIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-02-03 WO claimed
CN-113004170-A Covalent macrocyclic polymer based on column [5] arene and preparation and application thereof 天津孚信阳光科技有限公司 2021-06-22 CN claimed
CN-111097520-A Covalent organic framework material loaded Pd catalyst and preparation method and application thereof 中国科学院广州能源研究所 2020-05-05 CN claimed
US-8361484-B2 Polymer systems for lung volume reduction therapy AERIS THERAPEUTICS, INC. (US) 2013-01-29 US claimed
US-20100040538-A1 Polymer Systems for Lung Volume Reduction Therapy CANADIAN IMPERIAL BANK OF COMMERCE (CA) 2010-02-18 US claimed
EP-2059227-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY Aeris Therapeutics, Inc. (US) 2009-05-20 EP claimed
WO-2008039827-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY AERIS THERAPEUTICS, INC. (US) 2008-04-03 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250188096-A1 BENT OXAZOLE-BASED ORGANIC LINKERS FOR THE RETICULAR FORMATION OF METAL-ORGANIC FRAMEWORKS AND METHODS OF PREPARATION THEREOF OXA1L, MTCL3, OAT CA1 248/4885CA2 652/4885CA12 1061/4885
US-20100040538-A1 Polymer Systems for Lung Volume Reduction Therapy GFER, MUC1, CTH CA1 1918/4885CA2 2856/4885CA12 883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.